Literature DB >> 5394441

A pharmacologic guide to the clinical use of amphotericin B.

D D Bindschadler, J E Bennett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5394441     DOI： 10.1093/infdis/120.4.427

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  68 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

4.  Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride.

Authors:  Chandeshwar P Thakur; A Kumar; Dipendra K Mitra; Ambak Roy; Arun Kumar Sinha; Alok Ranjan
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

5.  Effect of amphotericin B and clotrimazole on lymphocyte stimulation.

Authors:  A Tärnvik; S Ansehn
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

6.  5-fluorocytosine and amphotericin B in bronchial secretions.

Authors:  J E Pennington; E R Block; H Y Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

7.  Successful treatment with liposomal amphotericin B in two patients with persisting fungemia.

Authors:  J P Sculier; D Bron; A Coune; F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

8.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

9.  Pharmacokinetics of liposomal amphotericin B in pleural fluid.

Authors:  Brad Moriyama; Parizad Torabi-Parizi; Alexandra K Pratt; Stacey A Henning; Gennethel Pennick; Yvonne R Shea; Sinchita Roy Chowdhuri; Michael G Rinaldi; A John Barrett; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

10.  In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.

Authors:  J W Brandsberg; M E French
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.